Update: First direct US product launch
NovaBay has initiated a direct sales and marketing campaign in the US for i-Lid Cleanser, its 0.01% pure hypochlorous acid product to treat conditions of the lids and lashes, including blepharitis. A small sales force of 10 reps will initially market i-Lid Cleanser, a prescription-only product, to optometrists and ophthalmologists across selected US cities. Sales force expansion in 4-6 months would follow successful uptake. This adds diversity to NovaBay’s portfolio ahead of important Phase IIb results in August for auriclosene in viral conjunctivitis, a significant share catalyst.NovaBay Pharmaceuticals is a medical device company primarily focused on eye care. The company is focused on commercializing Avenova?, a prescription product sold in the United States for cleansing and removing foreign material including microorganisms and debris from skin around the eye, including the eyelid. Avenova is an eye care product formulated with the company's proprietary hypochlorous acid. The company has developed additional products including NeutroPhase? for the wound care market and CelleRx? for the dermatology market. The company's second product category includes auriclosene, its key clinical-stage Aganocide compound, which is a synthetic molecule with a range of uses against bacteria, viruses and fungi.
Edison is an investment research and advisory company, with offices in North America, Europe, the Middle East and AsiaPac. The heart of Edison is our world renowned equity research platform and deep multi-sector expertise. At Edison Investment Research, our research is widely read by international investors, advisors and stakeholders. Edison Advisors leverages our core research platform to provide differentiated services including investor relations and strategic consulting.
.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.